Clinical Trials · NCT04748042
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- University of Michigan Rogel Cancer Center
- Enrollment
- 21
- Start date
- May 2021
- Locations
- 1 site, United States
- Primary endpoint
- Percentage of patients without treatment failure at 24 months